Jordan Hubbard

Apr 17, 2017

Jordan Hubbard has joined Two Pore Guys as vice president of engineering, where he will oversee the development of software and hardware for the company's nanopore-based single-molecule biosensor. Previously, Hubbard served as a manager and director of engineering at Apple, and headed up the FreeBSD project, an open-source UNIX variant that became a core technology in Apple's products.

More Like This

Aug 23, 2017

Herman Rosenman

Herman Rosenman has been appointed to the board of directors of DermTech. Rosenman was most recently CFO at Natera, from January 2014 to January 2017. Prior to that he was senior vice president of finance and CFO at Gen-Probe (now part of Hologic). He has also served as president and CEO of RadNet Management and CFO of Rexene.

Aug 23, 2017

Andy Page

Former 23andMe President Andy Page has joined consumer digital heath firm Livongo Health as its president and CFO. Page joined 23andMe in 2012 and became its president the following year. He left the company late last year. Prior to 23andMe, Page held several executive positions at other consumer technology companies, including president of Gilt Groupe, and CFO at PlayPhone and StubHub. 

Aug 23, 2017

Heiner Dreismann

Heiner Dreismann has joined Stemina Biomarker Discovery's board of directors. Dreismann is former president and CEO of Roche Molecular Systems and global head of business development for Roche Diagnostics. Stemina said that his experience will aid the company as its neurological disorders division, NeuroPointDx, prepares a metabolomics-based autism diagnostic test panel for market.

Aug 18, 2017

Richard Larkin

Chembio Diagnostics CFO Richard Larkin has told the firm he will retire by the end of the year. An external search to replace Larkin, who is also an executive vice president at Chembio, will begin immediately. Larkin will continue as CFO until Dec. 31, 2017, or until a successor is found, whichever is earlier. 

Aug 16, 2017

Bob King

Bob King has been named vice president of sales at Episona, where he will oversee the commercial expansion of the company's Seed test for evaluating male factor infertility and embryo quality. Most recently, he was director of business development and strategic accounts at Good Start Genetics. Previously, he was area sales director at Natera.

Aug 14, 2017

Sherrie Perkins, Andrew Theurer, Edgar Braendle

Sherrie Perkins has accepted the postion of CEO of ARUP Laboratories, while Andrew Theurer has accepted the position of president at the lab. They replace Edgar Braendle who served in both positions during the past year. Braendle is leaving ARUP to pursue other opportunities and rejoin his family in New Jersey, ARUP said. Perkins was previously senior vice president of R&D at ARUP, as well as professor, vice chair, and division chief of clinical pathology. She is a tenured professor at the University of Utah School of Medicine. Theurer was senior VP and CFO at ARUP. 

Aug 08, 2017

John Rice

Meridian Bioscience has appointed John Rice as an independent director. Rice joins Meridian from CincyTech, a firm that provides advice and capital to entrepreneurs and helps research institutions commercialize technology through startups. He has served as the director of life sciences since 2014. Rice is also the founder and, since 2003, managing partner of Triathlon Medical Ventures Partners, a venture capital firm that invests equity capital in early- and expansion-stage life science companies.

Aug 07, 2017

Paul Marr

MDxHealth has appointed Paul Marr to the post of executive VP of sales for North America. Marr previously served as VP of sales, North America for Beckman Coulter, and also has worked for Hologic, Gen-Probe, Leica Biosystems, Bayer Diagnostics, and Siemens Healthcare. He joins MDxHealth, which is based in Belgium, in conjunction with the firm's expansion of its US sales force to 50 representatives.

Aug 04, 2017

Madhuri Hegde

Madhuri Hegde has has been elected to the ACMG Foundation for Genetic and Genomic Medicine Board of Directors, the supporting educational foundation of the American College of Medical Genetics and Genomics. Hegde joined PerkinElmer in 2016 as vice president and CSO of Global Genetics Laboratory Services. She also is an adjunct professor of human genetics at Emory University. Previously, Hegde was executive director and CSO at Emory Genetics Laboratory in Atlanta; professor of human genetics and pediatrics at Emory University; and assistant professor of human genetics and senior director at Baylor College of Medicine in Houston.

Aug 03, 2017

Marijn Dekkers

Quanterix named Marijn Dekkers to its board. He is currently a board member at General Electric and is chairman of Unilever. He was previously CEO of Bayer and of Thermo Fisher Scientific. 

Aug 02, 2017

Bill Rastetter, Jeff Huber, Ken Drazan

Grail, a company aiming to develop a blood test for early cancer detection, has named Bill Rastetter, current chair of the company's board of directors, as its new CEO. Founding CEO Jeff Huber is now vice chairman of the board of directors, and Ken Drazan has been promoted from chief business officer to president.

Aug 02, 2017

Abraham Tzou

Freenome has appointed Abraham Tzou as its VP of regulatory affairs. Tzou will be in charge of regulatory strategy for products developed by Freenome and manage submissions to the US Food and Drug Administration and oversight bodies abroad.  

Tzou joins Freenome after serving as a medical officer at the FDA's Center for Devices and Radiological Health, where he led the clinical evaluation of in vitro diagnostics for cancer screening and prognosis, genetic disorders, and companion tests. During his tenure at the agency, he received commendation for his part in a team that reviewed Exact Sciences' non-invasive, colon cancer screening test Cologuard for parallel review. 

Freenome is developing a non-invasive cancer screening technology that involves genome-wide sequencing and a computational system, called Adaptive Genomics Engine. The company is interested in pursuing Parallel Review for this technology, which if successful, would enable simultaneous FDA approval and a national coverage determination from the Centers for Medicare & Medicaid Services.

Jul 31, 2017

Romney Humphries

Accelerate Diagnostics has appointed Romney Humphries as chief scientific officer. Prior to joining Accelerate Diagnostics, Humphries served as section chief for clinical microbiology and assistant clinical professor in the department of pathology and laboratory medicine at the UCLA Medical Center. Humphries currently serves on several committees and working groups for organizations including the American Society for Microbiology, the Clinical Laboratory and Standards Institute, the US Food and Drug Administration, and the World Health Organization.

Jul 26, 2017

Scott Howell

Tenet Diagnostics has appointed Scott Howell its CMO. He was most recently executive medical director at Heritage Provider Network. He also continues to practice at Kaiser Permanente Los Angeles Medical Center in the addiction medicine department. He was previously national senior medical director and chief medical officer Network and Population Health, Optim Insight, regional CMO Northeast region of Americhoice, and national medical director of managed care for AIDS Healthcare Foundation. 

Jul 25, 2017

David Barka, Nikhil Vazirani

Erba Diagnostics said that effective Aug. 1, David Barka will become the interim CEO and Nikhil Vazirani will join the firm's board. Barka has been the vice president of Calbiotech since 2004, and as president of Calbiotech Veterinary Diagnostics since 2017. He also has been president of Microplate Dispensers, dba Moduline Systems, since 2013. He plans to continue serving in those roles, Erba said. Vazirani has been the managing director of Erba Diagnostics Mannheim since April 2016, and a director of Erba Diagnostics UK and the interim CEO of Erba Lachema since this past February. He plans to continue serving in those roles.